Citation: | Wang Shixuan, . Serum soluble interleukin~2 receptor (sIL~2R) and CA125 assay in ovarian cancer[J]. Cancer Research on Prevention and Treatment, 1998, 25(4): 257-259. |
[1] |
周先荣,杜心谷.卵巢癌的发生及发生相关因素.国外医学妇产科学分册,1994,21(4):202
|
[2] |
Gadducci A, Ferdeghini M,malagnino G et al. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer. Gynecol Oncol 1994 Mar,1952(3):386
|
[3] |
Pavlidis NA, Bairaktari E,Kalef-Ezra J et al. Serum soluble interleukin 2 receptors in epithelial ovarian cancer patients. Int J Biol Markers。1995,10(2),75
|
[4] |
Wang Shixuan(王世宣),Cai Guiru, Lu Yunping. Clinical significance of sll.-2R levels in ovarian cancer. J Tongji Medical University 1998,1,58
|
[5] |
施伟,章英剑,蒋长英,等.肿瘤相关抗原CA125诊断卵巢上皮癌的敏感性及对疗效的观察.中华妇产科杂志,1994,29:604
|
[6] |
Hurteau JA, Woolas RP, Jacobs IJ,et al. Soluble inter-Leukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasmas and epithelial ovarian cancer. Cancer,1995,76(9):1615
|
[7] |
郁琦,连利娟.血清CA125测定和放射免疫显像对卵巢上皮癌的检测作用.中华妇产科杂志,1991,26: 235
|
[8] |
DePriest PD, Varner E,Powell J, et al. The efficacy of a sonographic morphology index in identifing ovarian cancer. Gynecol Oncol,1994,55,174
|